11:04 AM EST, 12/23/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk ( NVO ) and semiconductor company Sequans Communications ( SQNS ) , which rose 3.2% and 2.8% respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and accommodations booking company trivago (TRVG), which were up 2.7% and 1.5% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ), which fell 2.9%, followed by biotech firm Evaxion Biotech ( EVAX ) and internet advertising firm Criteo ( CRTO ) , which lost 2.3% each. They were followed by 3D printer company Materialise (MTLS), which was down 2%.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma ( VRNA ) and TC Biopharm ( TCBP ) , which rose 3.7% and 3.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and software firm Endava ( DAVA ) , which increased 2.1% and 1.8% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Autolus Therapeutics ( AUTL ) , which dropped 4.3% and 3.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and pharmaceutical company Silence Therapeutics ( SLN ) , which lost 3.3% and 3.2% respectively.